(Q44418470)

English

Cardiac morbidity in advanced chronic myelogenous leukaemia patients treated by successive allogeneic stem cell transplantation with busulphan/cyclophosphamide conditioning after imatinib mesylate administration

scientific article published in May 2003

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Cardiac morbidity in advanced chronic myelogenous leukaemia patients treated by successive allogeneic stem cell transplantation with busulphan/cyclophosphamide conditioning after imatinib mesylate administration (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Sang Kyun Sohn

1

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Jong Gwang Kim

2

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Dong Hwan Kim

3

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Kyu Bo Lee

4

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

language of work or name

0 references

publication date

1 May 2003

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

British Journal of Haematology

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

121

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

469-472

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Adverse events after imatinib mesylate therapy

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04288.X

21 January 2018

Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04288.X

21 January 2018

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04288.X

21 January 2018

Safety and efficacy of STI-571 (imatinib mesylate) in patients with bcr/abl-positive chronic myelogenous leukemia (CML) after autologous peripheral blood stem cell transplantation (PBSCT).

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04288.X

21 January 2018

Imatinib mesylate-induced hepato-toxicity in chronic myeloid leukemia demonstrated focal necrosis resembling acute viral hepatitis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04288.X

21 January 2018

Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04288.X

21 January 2018

Identifiers

10.1046/J.1365-2141.2003.04288.X

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

release_ccdk7xualnabzidbluqizai664

1 reference

https://api.fatcat.wiki/v0/release/ccdk7xualnabzidbluqizai664

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44418470&oldid=2022485860"